This pricing structure reflects the reality that the half-life benefit (weekly convenience and steady medication levels) applies equally whether you're at a lower starting dose or a higher therapeutic dose
De Greef D, Barton EM, Sandberg EN, Croley CR, Pumarol J, Wong TL, et al
What Consumers Should Know About GLP-1 Evidence and FeelGood's Brand-Stated Outcome Claims There are two separate issues consumers should not confuse: the clinical evidence for FDA-approved GLP-1 medications in appropriate patients, and FeelGood's brand-stated outcome claims for its own telehealth program
Reputable platforms use accredited 503A or 503B compounding pharmacies
Retatrutide should also not be combined with other GLP-1 or GIP agonist compounds like Semaglutide, Tirzepatide, or Liraglutide
Why Use Semaglutide for Weight Loss